Display Settings:

Format

Send to:

Choose Destination

    Vox Sang. 2008 Jul;95(1):76-8. Epub 2008 Apr 2.

    Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation.

    Lefrère JJ, Laperche S, Roudot-Thoraval F.

    Department of Blood-Transmissible Agents, National Institute of Blood Transfusion, Paris, France. jeanjacqueslefrere@orange.fr

    Being an orphan virus despite a large number of investigations, hepatitis G virus is a blood-borne agent for which screening is not required in blood donations. The in vivo efficacy of pathogen inactivation methods could be assessed by the absence of hepatitis G virus markers after transfusion of pathogen-inactivated blood products, in recipients susceptible to infection before the transfusion.

    PMID: 18393946 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read